Atomo Diagnostics is introducing its integrated rapid blood test device to the USA market at the 2014 AACC following a successful presentation at the 20th International AIDS Conference 2014 in Melbourne, Australia.
At AIDS 2014, Atomo Diagnostics participated in the ‘Realising Potential for HIV Self-testing’ conference session organized by the World Health Organisation (WHO). The session focused on opportunities and challenges facing self-testing and to debate thinking on real world situations.
The AtomoRapid all-in-one blood test can accommodate test strips for a wide variety of conditions from celiac disease and allergy through to infectious diseases such as malaria and HIV. The device delivers better clinical outcomes for patients and health care providers by enabling simpler, safer and more accurate testing in the field or at home. AtomoRapid all-in-one blood test, which is half the size of an iPhone, has been deployed in South Africa for HIV and malaria testing, and clinical activities are in process in the EU and in planning in Asia and USA.
“We have seen from our work with the Desmond Tutu HIV Foundation in South Africa that if you want to be accepted as an at-home test you need an integrated intuitive solution that reduces test errors,” says Atomo Diagnostics’ founder and CEO John Kelly.”Over 100 million rapid HIV tests are bought each year globally, and Atomo Diagnostics is leading the transition to more user friendly all-in-one solution with its AtomoRapid innovation.” Read more about the AtomoRapid all-in-one blood test.
Read more
